Noah Solomon

OverviewAI-generated summary

Noah Solomon's research focuses on the development and characterization of novel therapeutic antibodies for cancer treatment. His work includes the investigation of bispecific antibodies designed to target and degrade specific proteins involved in tumor growth. One area of his research involves bispecific antibodies that degrade EGFR for the treatment of solid tumors driven by EGFR mutations. He also studies bispecific degrader antibody-drug conjugates that combine c-MET degradation with cytotoxic payload delivery to address limitations in current c-MET-targeted therapies. Furthermore, Solomon's research encompasses the discovery of bispecific antibodies that degrade cKit, demonstrating efficacy in preclinical models of GIST. His publications also extend to optical probing techniques for extracting large language model assets from edge AI chips, and theoretical work on matroid correspondence, alongside functional characterization of effector proteins in plant-nematode interactions.

Metrics

• Publications: 7